Diagnosis and Treatment of Angiography Positive Medium to Large Vessel Childhood Primary Angiitis of Central Nervous System (p-cPACNS): An International Survey.
CNS
CNS inflammation
childhood
diagnosis
inflammation
pediatric
treatment
vasculitis
Journal
Frontiers in pediatrics
ISSN: 2296-2360
Titre abrégé: Front Pediatr
Pays: Switzerland
ID NLM: 101615492
Informations de publication
Date de publication:
2021
2021
Historique:
received:
16
01
2021
accepted:
08
03
2021
entrez:
12
4
2021
pubmed:
13
4
2021
medline:
13
4
2021
Statut:
epublish
Résumé
Childhood Primary Angiitis of Central Nervous System (cPACNS) is rare, but can cause significant damage and result in disability or even death. Because of its rarity, the sometimes acute and variable presentation, limited awareness, and the absence of widely accepted diagnostic and therapeutic standards, cPACNS is a diagnostic and therapeutic challenge. Three subcategories of cPACNS exist, including angiography-positive non-progressive p-cPACNS, angiography-positive progressive p-cPACNS which both affects the medium to large vessels, and angiography-negative small vessel sv-cPACNS. Diagnosis and treatment of cPACNS relies on personal experience, expert opinion and case reports/case series. To collect information on diagnostic and therapeutic approaches to transient and progressive cPACNS, a survey was shared among international clinicians (German Society for Pediatric Rheumatology, the Pediatric Rheumatology European Society, the German speaking "Network Pediatric Stroke," and members of the American College of Rheumatology/CARRA Pediatric Rheumatology list server). Results from this survey will be used to define statements toward a consensus process allowing harmonization of diagnostic and therapeutic approaches and the generation of evidence in a rare condition.
Identifiants
pubmed: 33842414
doi: 10.3389/fped.2021.654537
pmc: PMC8032958
doi:
Types de publication
Journal Article
Langues
eng
Pagination
654537Informations de copyright
Copyright © 2021 Quan, Brunner, Rose, Smitka, Hahn, Pain, Häfner, Speth, Gerstl and Hedrich.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Curr Rheumatol Rep. 2006 Dec;8(6):442-9
pubmed: 17092443
Arthritis Rheum. 2006 Apr;54(4):1291-7
pubmed: 16575852
Rheumatology (Oxford). 2019 Apr 1;58(4):656-671
pubmed: 30535249
J Clin Neurol. 2017 Apr;13(2):129-137
pubmed: 28176500
Continuum (Minneap Minn). 2013 Aug;19(4 Multiple Sclerosis):1058-73
pubmed: 23917101
Medicine (Baltimore). 1988 Jan;67(1):20-39
pubmed: 3275856
Ther Adv Neurol Disord. 2018 Jul 09;11:1756286418785071
pubmed: 30034536
Radiographics. 2018 Jul-Aug;38(4):997-1021
pubmed: 29883266
Ann Rheum Dis. 2018 Mar;77(3):319-327
pubmed: 29021237
Cleve Clin J Med. 1992 May-Jun;59(3):293-306
pubmed: 1516217
J Clin Immunol. 2018 Jul;38(5):569-578
pubmed: 29951947
Neurol Neuroimmunol Neuroinflamm. 2019 May 03;6(4):e567
pubmed: 31355303
Pediatr Rheumatol Online J. 2018 Jan 22;16(1):7
pubmed: 29357887
Lupus. 2020 Apr;29(5):474-481
pubmed: 32233733
Viruses. 2018 Nov 02;10(11):
pubmed: 30400213
Front Immunol. 2014 Aug 18;5:399
pubmed: 25183963
Curr Rheumatol Rep. 2018 May 30;20(7):37
pubmed: 29846828
Nat Rev Rheumatol. 2011 Dec 20;8(2):97-107
pubmed: 22183571
Clin Exp Rheumatol. 2017 Mar-Apr;35 Suppl 103(1):213-220
pubmed: 28375836
Front Pediatr. 2020 Jul 03;8:281
pubmed: 32719754
J Rheumatol. 2007 Jan;34(1):224-6
pubmed: 17117484
Trop Doct. 2017 Apr;47(2):158-164
pubmed: 28092221
Lancet Neurol. 2011 Jun;10(6):561-72
pubmed: 21601163
Arch Neurol. 2009 Jun;66(6):704-9
pubmed: 19506130
Curr Opin Pediatr. 2004 Dec;16(6):617-22
pubmed: 15548922
AJNR Am J Neuroradiol. 2006 Jan;27(1):192-9
pubmed: 16418382
Pediatr Rheumatol Online J. 2019 Jul 15;17(1):43
pubmed: 31307476